A novel subgroup of ACDase deficiency, SMA-PME, does not present with classical signs or symptoms of FD, adding a new challenge to diagnosis and treatment of this disorder [16]. This evidence concerns the gene ASAH1 and Progressive myoclonic epilepsy.